All Stories

  1. Next-generation vaccines for tropical infectious diseases
  2. Proteome profiling of cutaneous leishmaniasis lesions due to dermotropicLeishmania donovaniin Sri Lanka
  3. The use of recombinant K39, KMP11, and crude antigen-based indirect ELISA as a serological diagnostic tool and a measure of exposure for cutaneous leishmaniasis in Sri Lanka
  4. Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects
  5. Diagnostic Tools for Cutaneous Leishmaniasis Caused by Leishmania donovani: A Narrative Review
  6. Histological findings associated with treatment response in cutaneous leishmaniasis: a clinicopathological correlation study
  7. First evidence of experimental genetic hybridization between cutaneous and visceral strains of Leishmania donovani within its natural vector Phlebotomus argentipes
  8. Unfolded protein response pathway in leishmaniasis: A review
  9. Impact of climatic factors on temporal variability of sand fly abundance in Sri Lanka: Longitudinal study (2018 to 2020) with two-stage hierarchical analysis.
  10. Unfolded Protein Response (UPR) Pathway in cutaneous leishmaniasis: A review
  11. Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani
  12. Atypical Leishmania donovani Infections in Sri Lanka: Challenges for Control and Elimination
  13. Assessment of knowledge and perceptions on leishmaniasis: An island-wide study in Sri Lanka
  14. ELISA ‐based evaluation of antibody response to Leishmania in a region endemic for cutaneous leishmaniasis
  15. Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani
  16. An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
  17. Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review
  18. Stress conditions promote Leishmania hybridization in vitro marked by expression of the ancestral gamete fusogen HAP2 as revealed by single-cell RNA-seq
  19. Malaria
  20. Image Processing for mHealth-Based Approach to Detect the Local Tissue Inflammation in Cutaneous Leishmaniasis: A Proof of Concept Study
  21. Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination
  22. Genetic diversity and population structure of Phlebotomus argentipes: Vector of Leishmania donovani in Sri Lanka
  23. Spatiotemporal distribution of cutaneous leishmaniasis in Sri Lanka and future case burden estimates
  24. Therapeutic Response to Thermotherapy in Cutaneous Leishmaniasis Treatment Failures for Sodium Stibogluconate: A Randomized Controlled Proof of Principle Clinical Trial
  25. Author Correction: A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain
  26. First Evidence from Sri Lanka for Subphenotypic Diversity within L. donovani-Induced Classical Cutaneous Leishmaniasis
  27. Current situation of leishmaniasis in Bhutan and the potential for its elimination
  28. The role of improved housing and living environments in malaria control and elimination
  29. First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Leishmania donovani Induced CL in Sri Lanka
  30. Use of a Plasmodium vivax genetic barcode for genomic surveillance and parasite tracking in Sri Lanka
  31. Atypical Presentation of Post-Kala-Azar Dermal Leishmaniasis in Bhutan
  32. Insecticide susceptibility of the sand fly leishmaniasis vector Phlebotomus argentipes in Sri Lanka
  33. High resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis
  34. Quantification of Soluble or Insoluble Fractions ofLeishmaniaParasite Proteins in Microvolume Applications: A Simplification to Standard Lowry Assay
  35. Spatial Epidemiologic Trends and Hotspots of Leishmaniasis, Sri Lanka, 2001–2018
  36. Health in rural Sri Lanka: A cross-sectional survey of three rural districts
  37. First Evidence for Two Independent and Different Leishmaniasis Transmission Foci in Sri Lanka: Recent Introduction or Long-Term Existence?
  38. A highly sensitive modified nested PCR to enhance case detection in leishmaniasis
  39. A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain
  40. Leishmania donovani Induced Cutaneous Leishmaniasis: An Insight into Atypical Clinical Variants in Sri Lanka
  41. Trends in Recently Emerged Leishmania donovani Induced Cutaneous Leishmaniasis, Sri Lanka, for the First 13 Years
  42. Host genetic polymorphisms and serological response against malaria in a selected population in Sri Lanka
  43. Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain
  44. Cutaneous leishmaniasis in Sri Lanka: effect on quality of life
  45. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
  46. Challenges to eliminate leishmaniasis from South Asia
  47. Tissue Impression Smears as a Supplementary Diagnostic Method for Histopathology in Cutaneous Leishmaniasis in Sri Lanka
  48. First scientific evidence for a antibody response of leishmaniasis in Sri Lanka
  49. Genetic diversity of Leishmania donovani that causes cutaneous leishmaniasis in Sri Lanka: a cross sectional study with regional comparisons
  50. Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies
  51. Efficacy, Safety and Cost-Effectiveness of Thermotherapy in the Treatment of Leishmania donovani–Induced Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial
  52. Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat
  53. Case report of Plasmodium ovale curtisi malaria in Sri Lanka: relevance for the maintenance of elimination status
  54. In situ immunopathological changes in cutaneous leishmaniasis due toLeishmania donovani
  55. Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka
  56. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting
  57. Genomic analysis of local variation and recent evolution in Plasmodium vivax
  58. Loop-mediated isothermal amplification assay as a sensitive diagnostic tool for Leishmania donovani infections in Sri Lanka
  59. Admixture into and within sub-Saharan Africa
  60. Effect of human genes in developing cutaneous leishmaniasis
  61. Macrophage cell responses in cutaneous leishmaniasis caused by Leishmania donovani
  62. HLA determinants of susceptibility and protection to L. donovani: in silico analysis
  63. Leishmaniasis: Path toward elimination from the Indian subcontinent
  64. Nonresponsiveness to standard treatment in cutaneous leishmaniasis: A case series from Sri Lanka
  65. An E-mail interview with Dr. Nadira Karunaweera, Senior Professor and Chair, Head of Department Parasitology, Faculty of Medicine, University of Colombo, Sri Lanka
  66. Characterisation of cutaneous leishmaniasis in Matara district, southern Sri Lanka: evidence for case clustering
  67. Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study
  68. Genetic determinants of anti-malarial acquired immunity in a large multi-centre study
  69. Plasmodium vivax Diversity and Population Structure across Four Continents
  70. Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka
  71. Advances in genetics and genomics: use and limitations in achieving malaria elimination goals
  72. Development of a Single Nucleotide Polymorphism Barcode to Genotype Plasmodium vivax Infections
  73. G6PD gene variants and its association with malaria in a Sri Lankan population
  74. Integrated School-Based Surveillance for Soil-Transmitted Helminth Infections and Lymphatic Filariasis in Gampaha District, Sri Lanka
  75. The Sri Lankan paradox: high genetic diversity in Plasmodium vivax populations despite decreasing levels of malaria transmission
  76. Megaselia scalaris (Diptera: Phoridae) can live on ripe bananas - a potential health hazard?
  77. On the road to eliminate malaria in Sri Lanka: lessons from history, challenges, gaps in knowledge and research needs
  78. Health research towards nation development
  79. Leishmaniasis in Sri Lanka: a decade old story
  80. Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka
  81. Distribution Pattern of Plasmodium falciparum Chloroquine Transporter (pfcrt) Gene Haplotypes in Sri Lanka 1996–2006
  82. First successful in vitro culture of autochthonous Leishmania sp.<.i> in Sri Lanka
  83. Clinical features, risk factors and efficacy of cryotherapy in cutaneous leishmaniasis in Sri Lanka
  84. Efficacy of a five-day course of primaquine in preventing relapses in Plasmodium vivax malaria - a pilot study
  85. Bertiella studeri infection: resistance to niclosamide
  86. Evaluation of a rapid whole blood immunochromatographic assay for the diagnosis of Plasmodium falciparum and Plasmodium vivax malaria
  87. Co‐infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency
  88. Clinical and epidemiological studies on the cutaneous leishmaniasis caused byLeishmania(Leishmania)donovaniin Sri Lanka
  89. Study of dirofilariasis in a selected area in the Western Province
  90. Geographic Structure of Plasmodium vivax: Microsatellite Analysis of Parasite Populations from Sri Lanka, Myanmar, and Ethiopia
  91. Single-nucleotide polymorphism, linkage disequilibrium and geographic structure in the malaria parasite Plasmodium vivax: prospects for genome-wide association studies
  92. Imported drug-resistant severe malaria
  93. Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep's clothing?
  94. A simple, cost effective method for isolation and transportation of
  95. Genome-wide and fine-resolution association analysis of malaria in West Africa
  96. A global network for investigating the genomic epidemiology of malaria
  97. Costs and effectiveness of application of Poecilia reticulata (guppy) and temephos in anopheline mosquito control in river basins below the major dams of Sri Lanka
  98. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients
  99. Efficacy of RPMI 1640 and M 199 media in the isolation ofLeishmaniafrom cutaneous lesions
  100. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax
  101. Larvivorous Potential of the Guppy, Poecilia reticulata, in Anopheline Mosquito Control in Riverbed Pools Below the Kotmale Dam, Sri Lanka
  102. Cutaneous leishmaniasis in southern Sri Lanka
  103. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka
  104. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka
  105. Population Structure and Transmission Dynamics of Plasmodium vivax in Rural Amazonia
  106. Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
  107. Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation
  108. Fourteen polymorphic microsatellite DNA markers for the human malaria parasite Plasmodium vivax
  109. Anopheline breeding in river bed pools below major dams in Sri Lanka
  110. Microculture for the isolation ofLeishmania, modified to increase efficacy: a follow-up to a previous study
  111. Microculture for the isolation ofLeishmaniaparasites from cutaneous lesions — Sri Lankan experience
  112. Effects of climatic, socio–economic and behavioural factors on the transmission of hookworm (Necator americanus) on two low-country plantations in Sri Lanka
  113. Malarial vectors in an irrigated rice cultivation area in southern Sri Lanka
  114. Wet-days: are they better indicators of Ascaris infection levels?
  115. Socio–economic and behavioural factors affecting the prevalence ofAscarisinfection in a low-country tea plantation in Sri Lanka
  116. A simple device to maintain in vitro cultures of Leishmania in tropical countries
  117. A cost analysis of the use of the rapid, whole-blood, immunochromatographic P.f/P.v assay for the diagnosis ofPlasmodium vivaxmalaria in a rural area of Sri Lanka
  118. Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37
  119. The paroxysm of Plasmodium vivax malaria
  120. Larvicidal effects of mineral turpentine, low aromatic white spirits, aqueous extracts of Cassia alata, and aqueous extracts, ethanolic extracts and essential oil of betel leaf (Piper betle) on Chrysomya megacephala
  121. A study of cutaneous myiasis in Sri Lanka
  122. Mediators and Mechanisms Associated with Paroxysm in Plasmodium vivax Malaria
  123. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria.
  124. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential.
  125. Anti-parasite effects of cytokines in malaria